In vitro antifungal activity and cytotoxicity of a novel membrane- active peptide

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1704-1707

  Hong, Sung Yu ^a   Oh, Jong Eun ^a   Lee, Keun Hyeung ^a  

^a Mogam Biotechnology Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; ENANTIOMER; FUNGICIDAL ACTIVITY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MAMMAL CELL; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0345593755     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1704     Document Type: Article

References (23)

1. Andreoli, T. E. 1974. The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes. Ann. N. Y. Acad. Sci. 235:448-468.
2. Andriole, V. T. 1993. Infections with Aspergillus species. Clin. Infect. Dis. 17(Suppl.):S481-S486.
3. Barra, D., and M. Simmanco. 1995. Amphibian skin: a promising resource for antimicrobial peptides. Trends Biotechnol. 13:205-209.
4. Bergstrom, J. D., C. Dufresne, G. F. Bills, M. Nallin-Omstead, and K. Byrne. 1995. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase. Annu. Rev. Microbiol. 49:607-639.
5. Berkowitz, B. A., C. L. Bevins, and M. A. Zasloff. 1990. Magainins: a new family of membrane-active host defense peptides. Biochem. Pharmacol. 39: 625-629.
6. Bodey, G., B. Bueltmann, W. Duguid, D. Gibbs, H. Hanak, M. Hotchi, G. Mall, P. Martino, F. Meunier, and S. Milliken. 1992. Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11:99-109.
7. Boman, H. G., and D. Hultmark. 1987. Cell-free immunity in insects. Annu. Rev. Microbiol. 41:103-126.
8. Cheron, M., B. Cybulska, J. Mazerski, J. Grzybowska, A. Czerwinski, and E. Borowski. 1988. Quantitative structure-activity relationships in amphotericin B derivatives. Biochem. Pharmacol. 37:827-836.
9. Fields, G. B., Z. Tian, and G. Barany. 1992. Synthetic peptide: a user's guide, p. 77-183. W. H. Freeman & Co., New York, N.Y.
10. Furka, A., F. Sebestyen, M. Asgedom, and G. Dibo. 1991. General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Peptide Protein Res. 37:487-493.
11. Georgopapadakou, N. H., and T. J. Walsh. 1994. Human mycoses: drugs and targets for emerging pathogens. Science 264:371-373.
12. Hata, K., J. Kimura, H. Miki, T. Toyosawa, T. Nakamura, and K. Katsu. 1996. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob. Agents Chemother. 40:2237-2242.
13. Heinz, D. W., W. A. Baase, and B. W. Matthews. 1992. Folding and function of T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence. Proc. Natl. Acad. Sci. USA 89:3751-3755.
14. Hong, S. Y., J. E. Oh, M. Y. Kwon, M. J. Choi, J. H. Lee, B. L. Lee, H. M. Moon, and K. H. Lee. 1998. Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. Antimicrob. Agents Chemother. 42:2534-2541.
15. Hong, S. Y., J. E. Oh, M. Y. Kwon, J. H. Lee, B. L. Lee, and K. H. Lee. Unpublished data.
16. Kinsky, S. C. 1970. Antibiotic interaction with model membranes. Annu. Rev. Pharmacol. 10:119-142.
17. Lam, K. S., S. E. Salmon, E. M. Hersh, V. J. Hruby, W. M. Kazmierski, and R. J. Knapp. 1991. A new type of synthetic peptide library for identifying ligand-binding activity. Nature (London) 354:82-84.
18. Mak, P., K. Wojcik, I. B. Thogersen, and A. Dubin. 1996. Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins. Infect. Immun. 64:4444-4449.
19. Orozco, A. S., L. M. Higginbotham, C. A. Hitchcock, T. Parkinson, D. Falconer, A. S. Ibrahim, M. A. Ghannoum, and S. G. Filler. 1998. Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother. 42:2645-2649.
20. Qu, X. D., S. S. Harwig, W. M. Shafer, and R. I. Lehrer. 1997. Protegrin structure and activity against Neisseria gonorrhoeae. Infect. Immun. 65:636-639.
21. Rodriguez-Tudela, J. L., J. Berenguer, J. V. Martinez-Sugarez, and R. Sanchez. 1996. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrob. Agents Chemother. 40:1998-2003.
22. Sugawara, T., M. Shibazaki, H. Nakahara, and K. Suzuki. 1996. YM-47522, a novel antifungal antibiotic produced by Bacillus sp. II. Structure and relative stereochemistry. J. Antibiot. 49:345-348.
23. Zasloff, M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 84:5449.